Clinical Trial

Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of the study is to assess the effectiveness, feasibility, and acceptability of targeted drug administration for seasonal migrant populations in Metema District, Amhara Region, Ethiopia
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-07-17; most recent amendment 2025-05-02.
Status change: Recruiting → Active, Not Recruiting 2025-05-02
Status change: Not Yet Recruiting → Recruiting 2024-11-04
Trial Details
NCT Number NCT06516042
Lead Sponsor PATH
Collaborators: Federal Minstry of Health of Ethiopia
Conditions Plasmodium Falciparum, Malaria
Enrollment 10,350 participants
Start Date 2024-08-21
Primary Completion 2025-01-24 (estimated)
Study Completion 2025-07 (estimated)
Updated on ClinicalTrials.gov 2025-05-06